COR Cencora, Inc. Common Stock
Sobre Cencora, Inc. Common Stock Visão geral da empresa da Wikipedia
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Ler mais
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Background
AmerisourceBergen was formed in 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. David Yost was CEO of Amerisource prior to the merger and remained in the position after the companies merged.
AmerisourceBergen has 26 pharmaceutical distribution centers in the US, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production capacity in the US and the UK. With the addition of World Courier, the largest specialty courier company in the world, over 150 company-owned offices around the globe were added to the company.
AmerisourceBergen operates its pharmaceutical distribution business under four primary units: AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS) and World Courier. In March 2016, pharmacy Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company.
In 2012, the firm was the largest by revenue based in Pennsylvania. The company changed its name to Cencora as of August 30, 2023 and began trading on the New York Stock Exchange under the new ticker symbol "COR". In May 2024, Cencora disclosed it had been the subject of a cyber incident in which patient information was exposed.
Products
They provide drug distribution and consulting related to medical business operations and patient services. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to health care providers throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers' compensation and specialty drug patients.
AmerisourceBergen handles about 20% of all of the pharmaceuticals sold and distributed throughout the United States and ranked 10th on the Fortune 500 list for 2020 with over $179 billion in annual revenue.
Good Neighbor Pharmacy
Good Neighbor Pharmacy is an American retailers' cooperative network of more than 3,400 independently owned and operated pharmacies. It has a business affiliation with AmerisourceBergen, which sponsors the network and owns the name "Good Neighbor Pharmacy." Good Neighbor Pharmacy is the sponsor for "ThoughtSpot," the annual trade show held in both Orlando and Las Vegas.
Acquisition history
In 2011, the company acquired IntrinsiQ for $35 million and Premier Source for an undisclosed amount. In July, Steven Collis replaced Yost as CEO of the company.
In March 2012, AmerisourceBergen agreed to acquire World Courier Group Inc, a transportation and logistics provider for the biopharmaceutical industry, for $520 million.
In January 2015, the company bought MWI Veterinary for $2.5 billion. In October, they agreed to buy PharMEDium, a compounding drug company, for $2.58 billion.
On January 3, 2018, AmerisourceBergen acquired H. D. Smith, the largest privately held national pharmaceutical wholesaler in the U.S.
On June 2, 2021, AmerisourceBergen acquired Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion, made up of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock.
On January 2, 2025, Cencora acquired 85% of Retina Consultants of America for approximately $4.4 billion.
Distribution of Remdesivir
In June 2020, the U.S. Department of Health and Human Services (HHS) announced an unusual agreement for the distribution of remdesivir, the first coronavirus drug. HHS agreed to manufacturer Gilead's wholesale acquisition price, while HHS would continue to work together with state governments and AmerisourceBergen to allocate shipments of remdesivir vials to American hospitals through the end of September 2020, and in exchange, during that time-frame American patients would be allocated over 90% of Gilead's projected remdesivir output of more than 500,000 treatment courses.
Finances
For the fiscal year 2019, AmerisourceBergen reported earnings of US$1.11 billion, with an annual revenue of US$179.58 billion. AmerisourceBergen's shares traded at over $88 per share, and its market capitalization was valued at over US$19.2 billion in September 2019.
Controversies
Opioid epidemic
AmerisourceBergen is among several distributors that have been sued by West Virginia for contributing to the opioid epidemic in the United States, by shipping inordinate amounts of pain medication into the state.
In December 2019, Michigan became the first state to sue AmerisourceBergen and three other opioid distributors as drug dealers for their role in the state's opioid crisis. The lawsuit is filed under the Michigan Drug Dealer Liability Act. AmerisourceBergen was among four companies who, because of their role in the addiction crisis, agreed to pay $260 million to two Ohio counties. In May 2020, Oklahoma Attorney General Mike Hunter sued AmerisourceBergen in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets." In January 2022, AmerisourceBergen, McKesson, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them. The deal covered the bulk of the grievances against these four companies, including 90 percent of municipal governments, 46 states, and Washington, DC. Had the states gone to court, the companies could have faced up to $95 billion in penalties. AmerisourceBergen and the three other companies did not admit wrongdoing.
Legal issues
In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks to physicians. The company had previously been found guilty of a misdemeanor charge related to the repackaging and distribution of pre-filled syringes that lacked FDA approval. In connection with this case, AmerisourceBergen agreed to pay $260 million, bringing the total settlement amount to $885 million.
As part of the civil settlement, ABC admitted that between January 2001 and January 2014, MII and OSC operated a program that created, packed and shipped millions of pre-filled syringes (PFS) to oncology practices for administration to vulnerable cancer patients (the PFS Program). At MII, an ABC subsidiary located in Alabama, the drug product was removed from the original glass vials and multiple vials of the product were pooled in untested plastic containers. Then the drug, including the overfill, was extracted and repackaged into syringes. By harvesting the overfill, ABC was able to create more doses than it bought from the original vial manufacturers and avoid opening some of the vials. ABC retained the unopened vials and sold them to other customers and to its subsidiary ABDC for resale. During the 13 years the PFS Program was in operation, MII manufactured thousands of syringes daily, and eventually over one million syringes per year. These syringes were sold throughout the United States. Approximately 57% of the patients who were injected with the PFS were Federal Health Care Program beneficiaries. The profit from the PFS Program was between $2.3 and $14.4 million annually for a total profit of at least $99.6 million.
ABC’s scheme enabled it to bill multiple health care providers for the same vial of drug, causing some of those providers to bill the Federal Health Care Programs for the same vial more than once. The scheme also enabled ABC to increase its market share by offering various product discounts, which it leveraged to obtain new customers and to keep existing customers who purchased its entire portfolio of oncology drugs. ABC excluded the entire PFS Program from its standard regulatory audit and pedigree compliance programs. AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. States countered with $45 billion.
In 2022, the United States government filed a lawsuit against AmerisourceBergen for contributing to the opioid crisis in America. The suit, which was filed by the United States Department of Justice with federal prosecutors in New Jersey, Colorado, Pennsylvania, and New York, alleged that the company distributed opioids that were later resold illegally.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
COR Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
COR Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor |
|---|---|
| 15 de Maio de 2026 | $0,6000 |
| 13 de Fevereiro de 2026 | $0,6000 |
| 14 de Novembro de 2025 | $0,6000 |
| 15 de Agosto de 2025 | $0,5500 |
| 16 de Maio de 2025 | $0,5500 |
| 14 de Fevereiro de 2025 | $0,5500 |
| 15 de Novembro de 2024 | $0,5500 |
| 9 de Agosto de 2024 | $0,5100 |
| 9 de Maio de 2024 | $0,5100 |
| 8 de Fevereiro de 2024 | $0,5100 |
| 10 de Novembro de 2023 | $0,5100 |
| 10 de Agosto de 2023 | $0,4850 |
| 11 de Maio de 2023 | $0,4850 |
| 9 de Fevereiro de 2023 | $0,4850 |
| 10 de Novembro de 2022 | $0,4850 |
| 12 de Agosto de 2022 | $0,4600 |
| 13 de Maio de 2022 | $0,4600 |
| 11 de Fevereiro de 2022 | $0,4600 |
| 1 de Dezembro de 2021 | $1,2700 |
| 12 de Novembro de 2021 | $0,4600 |
COR Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 5 25,0%
- Compra 10 50,0%
- Manter 5 25,0%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
12 analistas · 2026-08-13Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Setembro de 2026 | $4.48 | $4.39 | 0.09% |
| 30 de Junho de 2026 | $4.48 | $4.39 | 0.09% |
| 31 de Março de 2026 | $4.75 | $4.86 | -0.11% |
| 31 de Dezembro de 2025 | $4.08 | $4.08 | 0.00% |
| 30 de Setembro de 2025 | $3.84 | $3.82 | 0.02% |
| 30 de Junho de 2025 | $4.00 | $3.88 | 0.12% |
| 31 de Março de 2025 | $4.42 | $4.15 | 0.27% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Cost of Revenue | $309.85B | $284.05B | $253.21B | $230.29B | $207.05B | $184.70B | $174.45B | $163.33B | $148.60B | $142.58B | $132.43B | $116.59B | |
| Gross Profit | $11.48B | $9.91B | $8.96B | $8.30B | $6.94B | $5.19B | $5.14B | $4.61B | $4.55B | $4.27B | $3.53B | $2.98B | |
| SG&A Expense | $6.49B | $5.66B | $5.31B | $4.85B | $3.59B | $2.77B | $2.66B | $2.46B | $2.13B | $2.09B | $1.91B | $1.58B | |
| Operating Expenses | $6.99B | $6.09B | $5.72B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B | $-5.14B | $1.11B | $1.44B | $1.06B | $1.53B | $422M | $782M | |
| Other Non-op | $-79M | $-14M | $49M | $27M | $42M | $2M | $13M | $-25M | $3M | $5M | $-14M | $4M | |
| Pretax Income | $2.26B | $2.00B | $2.16B | $2.18B | $2.22B | $-5.29B | $967M | $1.18B | $918M | $1.39B | $269M | $670M | |
| Income Tax | $691M | $485M | $428M | $517M | $677M | $-1.89B | $113M | $-438M | $553M | $-37M | $407M | $388M | |
| Net Income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| EPS (Basic) | $8.02 | $7.60 | $8.62 | $8.15 | $7.48 | $-16.65 | $4.07 | $7.61 | $1.67 | $6.73 | $-0.63 | $1.21 | |
| EPS (Diluted) | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | $-16.65 | $4.04 | $7.53 | $1.64 | $6.32 | $-0.63 | $1.16 | |
| Shares (Basic) | 193,820,000 | 198,503,000 | 202,511,000 | 208,472,000 | 205,919,000 | 204,783,000 | 210,165,000 | 217,872,000 | 218,375,000 | 212,206,000 | 217,786,000 | 227,367,000 | |
| Shares (Diluted) | 195,214,000 | 200,284,000 | 204,591,000 | 211,210,000 | 208,465,000 | 204,783,000 | 211,840,000 | 220,336,000 | 221,602,000 | 225,959,000 | 217,786,000 | 235,405,000 | |
| EBITDA | $3.68B | $3.27B | $3.30B | $3.06B | $2.86B | $-4.74B | $1.57B | $1.91B | $1.46B | $1.89B | $661M | $964M |
Balanço Patrimonial 29
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.36B | $3.13B | $2.59B | $3.39B | $2.55B | $4.60B | $3.37B | $2.49B | $2.44B | $2.74B | $2.17B | $1.81B | |
| Receivables | $25.23B | $23.87B | $20.91B | $18.45B | $18.17B | $13.85B | $12.39B | $11.31B | $10.30B | $9.18B | $8.22B | $6.31B | |
| Inventory | $20.49B | $19.00B | $17.45B | $15.56B | $15.37B | $12.59B | $11.06B | $11.92B | $11.46B | $10.72B | $9.76B | $8.59B | |
| Prepaid Expense | $539M | $539M | $449M | $488M | $854M | $189M | $157M | $169M | $103M | $210M | $189M | $85M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $85M | |
| Current Assets | $52.24B | $47.72B | $42.80B | $39.59B | $38.80B | $33.06B | $28.13B | $25.89B | $24.30B | $22.85B | $20.33B | $16.80B | |
| PP&E (Net) | $2.54B | $2.18B | $2.14B | $2.14B | $2.16B | $1.48B | $1.77B | $1.89B | $1.80B | $1.53B | $1.19B | $900M | |
| PP&E (Gross) | $5.73B | $5.22B | $4.74B | $4.39B | $4.08B | $3.24B | $3.35B | $3.41B | $3.09B | $2.62B | $2.14B | $1.69B | |
| Accum. Depreciation | $3.19B | $3.03B | $2.60B | $2.25B | $1.92B | $1.76B | $1.58B | $1.52B | $1.29B | $1.09B | $950M | $793M | |
| Goodwill | $13.68B | $9.32B | $9.57B | $8.50B | $9.03B | $6.71B | $6.71B | $6.66B | $6.04B | $5.99B | $4.14B | $2.95B | |
| Intangibles | $3.77B | $4.00B | $4.43B | $4.33B | $5.26B | $1.89B | $2.29B | $2.95B | $2.83B | $2.97B | $1.99B | $533M | |
| Other Non-current Assets | $4.15B | $3.64B | $3.42B | $1.76B | $1.79B | $780M | $269M | $271M | $338M | $296M | $298M | $351M | |
| Total Assets | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Accounts Payable | $54.72B | $50.94B | $45.84B | $40.19B | $38.01B | $31.71B | $28.39B | $26.84B | $25.40B | $23.93B | $20.89B | $15.59B | |
| Accrued Liabilities | $2.98B | $2.76B | $2.35B | $2.21B | $2.86B | $1.65B | $1.06B | $881M | $1.40B | $744M | $692M | $562M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Current Liabilities | $57.82B | $54.28B | $48.83B | $43.48B | $41.36B | $33.85B | $29.58B | $27.87B | $26.82B | $25.28B | $21.58B | $17.25B | |
| Capital Leases | $1.42B | $1.03B | $924M | $864M | $946M | $386M | $321M | $352M | $352M | $276M | $246M | · | |
| Deferred Tax | $1.62B | $1.64B | $1.66B | $1.62B | $1.69B | $686M | $1.86B | $1.83B | $2.49B | $2.21B | $1.94B | $241M | |
| Other Non-current Liabilities | $3.64B | $1.99B | $1.88B | $977M | $1.08B | $473M | $99M | $110M | $75M | $160M | $85M | $88M | |
| Long-term Debt | $7.66B | $4.39B | $4.79B | $5.70B | $6.68B | $4.12B | $4.17B | $177M | $3.44B | $4.19B | $3.49B | $2.00B | |
| Total Debt | $7.54B | $3.81B | $4.15B | $4.63B | $6.38B | $3.62B | $4.03B | $4.17B | $3.43B | $3.59B | $3.49B | $2.00B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $6.53B | $5.42B | $4.32B | $2.98B | $1.67B | $518M | $4.24B | $3.72B | $2.40B | $2.30B | $1.16B | $1.57B | |
| Treasury Stock | $10.33B | $9.82B | $8.25B | $7.02B | $6.47B | $6.51B | $6.10B | $5.43B | $4.76B | $4.40B | $4.15B | $2.31B | |
| AOCI | $-901M | $-989M | $-1.40B | $-1.83B | $-445M | $-109M | $-112M | $-79M | $-96M | $-114M | $-136M | $-52M | |
| Stockholders' Equity | $1.51B | $646M | $522M | $-212M | $223M | $-1.02B | $2.88B | $2.93B | $2.06B | $2.13B | $616M | $1.94B | |
| Liabilities + Equity | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Shares Outstanding | 193,937,673 | 194,943,968 | 200,814,804 | 206,203,817 | 208,089,298 | 204,226,465 | 206,760,654 | 213,217,882 | 217,993,598 | 220,050,502 | 206,891,873 | 221,908,650 |
Fluxo de Caixa 19
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.05B | $1.09B | $964M | $694M | $505M | $391M | $462M | $465M | $398M | $365M | $249M | $189M | |
| Stock-based Comp | $148M | $148M | $125M | $93M | $100M | $74M | $59M | $62M | $62M | $65M | $61M | $43M | |
| Deferred Tax | $60M | $-102M | $-119M | $196M | $335M | $-1.54B | $29M | $-796M | $319M | $-131M | $21M | $38M | |
| Amort. of Intangibles | $557M | $663M | $554M | $307M | $178M | $111M | $167M | $181M | $161M | $152M | $56M | $26M | |
| Restructuring | $229M | $234M | $230M | $63M | $82M | $6.81B | $330M | $184M | $959M | $103M | $38M | $8M | |
| Other Non-cash | $1.06B | $838M | $1.20B | $21M | $187M | $6.70B | $939M | $21M | $361M | $1.45B | $3.73B | $919M | |
| Operating Cash Flow | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B | $2.21B | $2.34B | $1.41B | $1.50B | $3.18B | $3.92B | $1.46B | |
| CapEx | $668M | $487M | $458M | $496M | $438M | $370M | $310M | $336M | $466M | $465M | $232M | $264M | |
| Investing Cash Flow | $-4.98B | $-618M | $-2.60B | $-368M | $-6.14B | $-380M | $-376M | $-1.11B | $-498M | $-3.17B | $-2.93B | $-384M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $1.10B | |
| Net Debt Issued | $-1.28B | · | · | · | $-835M | $-598M | $-511M | $-681M | $-750M | $-800M | $-500M | $566M | |
| Stock Issued | · | · | · | $0 | $0 | $66M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | $435M | $1.49B | $1.18B | $484M | $82M | $420M | $674M | $639M | $330M | $2.27B | $1.86B | $754M | |
| Net Stock Activity | $-435M | $-1.49B | $-1.18B | $-484M | $-82M | $-354M | $-674M | $-639M | $-330M | $-2.27B | $-1.86B | $-754M | |
| Dividends Paid | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M | |
| Financing Cash Flow | $2.25B | $-2.33B | $-2.22B | $-1.75B | $1.95B | $-604M | $-1.09B | $-243M | $-1.31B | $565M | $-632M | $-503M | |
| Net Change in Cash | $1.10B | $545M | $-841M | $523M | $-1.53B | $1.22B | $882M | $57M | $-307M | $574M | $359M | $578M | |
| Taxes Paid | $571M | $604M | $463M | $244M | $94M | $139M | $118M | $104M | $105M | $18M | $300M | $197M | |
| Free Cash Flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B | $1.84B | $2.03B | $1.07B | $1.04B | $2.71B | $3.69B | $1.20B |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% | 2.7% | 2.9% | 2.8% | 3.0% | 2.9% | 2.6% | 2.5% | |
| Operating Margin | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% | -2.7% | 0.62% | 0.86% | 0.69% | 1.0% | 0.31% | 0.65% | |
| Net Margin | 0.48% | 0.51% | 0.67% | 0.71% | 0.72% | -1.8% | 0.48% | 0.99% | 0.24% | 0.97% | -0.10% | 0.23% | |
| Pretax Margin | 0.70% | 0.68% | 0.82% | 0.91% | 1.0% | -2.8% | 0.54% | 0.70% | 0.60% | 0.95% | 0.20% | 0.56% | |
| EBITDA Margin | 1.1% | 1.1% | 1.3% | 1.3% | 1.3% | -2.5% | 0.88% | 1.1% | 0.95% | 1.3% | 0.49% | 0.81% | |
| ROA | 2.2% | 2.3% | 2.9% | 3.0% | 3.0% | -8.2% | 2.2% | 4.5% | 1.1% | 4.6% | -0.55% | 1.4% | |
| ROE | 144.3% | 258.4% | 1124.4% | 28805.8% | -387.1% | -366.5% | 29.4% | 66.4% | 17.4% | 104.0% | -10.5% | 13.0% | |
| ROIC | 20.2% | 37.0% | 40.2% | 40.9% | 24.8% | -126.9% | 14.2% | 27.9% | 7.7% | 27.4% | -5.0% | 8.3% |
Liquidez e Solvência 4
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 | |
| LT Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.5 | 4.5 | 4.4 | 4.2 | 4.2 | 4.6 | 4.7 | 4.6 | 4.4 | 4.8 | 5.5 | 5.9 | |
| Inventory Turnover | 15.7 | 15.6 | 15.3 | 14.9 | 14.8 | 15.6 | 15.2 | 14.0 | 13.4 | 13.9 | 14.4 | 15.0 | |
| Receivables Turnover | 13.1 | 13.1 | 13.3 | 13.0 | 13.4 | 14.5 | 15.2 | 15.5 | 15.7 | 16.9 | 18.7 | 19.3 |
Taxas de Crescimento 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.1% | 9.9% | 11.5% | 12.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 11.2% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 5.7% | -11.7% | 6.1% | 8.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -0.33% | 0.63% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3.0% | -13.5% | 2.7% | 10.3% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.9% | -0.67% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Net Income TTM | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| Market Cap | $60.61B | $43.88B | $36.14B | $27.91B | $24.86B | $19.79B | $17.02B | $19.66B | $18.04B | $17.78B | $19.65B | $17.15B | |
| Enterprise Value | $63.80B | $44.56B | $37.69B | $29.15B | $28.69B | $18.81B | $17.68B | $21.34B | $19.03B | $18.63B | $20.98B | $17.34B | |
| P/E | 39.3 | 29.9 | 21.1 | 16.8 | 16.2 | -5.8 | 20.4 | 12.2 | 50.5 | 12.8 | -150.8 | 66.6 | |
| P/S | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| P/B | 40.2 | 67.9 | 69.2 | -131.9 | 111.3 | -19.4 | 5.9 | 6.7 | 8.7 | 8.3 | 31.0 | 8.8 | |
| P / Cash Flow | 15.6 | 12.6 | 9.2 | 10.3 | 9.3 | 9.0 | 7.3 | 13.9 | 12.0 | 5.6 | 5.0 | 11.7 | |
| P / FCF | 18.9 | 14.6 | 10.5 | 12.6 | 11.2 | 10.8 | 8.4 | 18.3 | 17.4 | 6.5 | 5.3 | 14.3 | |
| EV / EBITDA | 17.3 | 13.6 | 11.4 | 9.5 | 10.0 | -4.0 | 11.2 | 11.2 | 13.1 | 9.9 | 31.8 | 18.0 | |
| EV / FCF | 19.9 | 14.9 | 10.9 | 13.2 | 12.9 | 10.2 | 8.7 | 19.9 | 18.3 | 6.9 | 5.7 | 14.5 | |
| EV / Revenue | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
| Dividend Yield | 0.72% | 0.95% | 1.1% | 1.4% | 1.5% | 1.7% | 2.0% | 1.7% | 1.8% | 1.6% | 1.3% | 1.2% | |
| Earnings Yield | 2.5% | 3.4% | 4.7% | 5.9% | 6.2% | -17.2% | 4.9% | 8.2% | 2.0% | 7.8% | -0.66% | 1.5% | |
| Payout Ratio | 28.1% | 27.6% | 22.9% | 23.1% | 23.8% | -10.1% | 39.6% | 20.1% | 87.9% | 20.2% | -188.2% | 77.6% | |
| Annual Payout | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M |
Demonstração de Resultados 15
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.75B | $78.36B | $85.93B | $83.73B | $80.66B | $75.45B | $81.49B | $79.05B | $74.24B | $68.41B | $72.25B | $68.92B | $66.95B | $63.46B | $62.85B | $61.17B | |
| Cost of Revenue | $81.15B | $74.77B | $82.86B | $80.77B | $77.76B | $72.39B | $78.93B | $76.56B | $71.83B | $65.88B | $69.78B | $66.67B | $64.68B | $61.16B | $60.70B | $59.19B | |
| Gross Profit | $3.61B | $3.59B | $3.07B | $2.95B | $2.91B | $3.06B | $2.56B | $2.49B | $2.41B | $2.54B | $2.47B | $2.25B | $2.26B | $2.30B | $2.15B | $1.99B | |
| SG&A Expense | $2.13B | $1.98B | $1.80B | $1.75B | $1.67B | $1.60B | $1.47B | $1.49B | $1.38B | $1.39B | $1.40B | $1.39B | $1.30B | $1.32B | $1.29B | $1.26B | |
| Operating Expenses | $2.28B | $2.11B | $1.93B | $1.88B | $1.80B | $1.72B | $1.59B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $1.12B | $1.14B | $760M | $19M | $868M | $1.04B | $706M | $127M | $672M | $553M | $823M | $477M | $670M | $561M | $633M | $455M | |
| Other Non-op | $17M | $1.09B | $21M | $-128M | $110M | $-4M | $-58M | $20M | $-13M | $-22M | $1M | $30M | $-3M | $16M | $6M | $-21M | |
| Pretax Income | $996M | $2.09B | $709M | $-187M | $896M | $929M | $620M | $125M | $628M | $467M | $783M | $446M | $609M | $512M | $593M | $382M | |
| Income Tax | $220M | $459M | $143M | $146M | $207M | $211M | $127M | $118M | $141M | $46M | $180M | $97M | $130M | $84M | $117M | $84M | |
| Net Income | $764M | $1.64B | $560M | $-340M | $687M | $718M | $489M | $3M | $483M | $421M | $602M | $351M | $480M | $435M | $480M | $295M | |
| EPS (Basic) | $3.95 | $8.44 | $2.88 | $-1.75 | $3.55 | $3.70 | $2.52 | $0.04 | $2.44 | $2.11 | $3.01 | $1.75 | $2.37 | $2.15 | $2.35 | $1.43 | |
| EPS (Diluted) | $3.94 | $8.40 | $2.87 | $-1.74 | $3.52 | $3.68 | $2.50 | $0.04 | $2.42 | $2.09 | $2.98 | $1.72 | $2.35 | $2.13 | $2.33 | $1.40 | |
| Shares (Basic) | 193,147,000 | 194,545,000 | 194,219,000 | -387,556,000 | 193,822,000 | 193,796,000 | 193,758,000 | -399,244,000 | 198,260,000 | 199,406,000 | 200,081,000 | -406,186,000 | 202,349,000 | 202,316,000 | 204,032,000 | -418,212,000 | |
| Shares (Diluted) | 193,944,000 | 195,383,000 | 195,319,000 | -390,298,000 | 195,230,000 | 195,094,000 | 195,188,000 | -402,777,000 | 200,047,000 | 201,177,000 | 201,837,000 | -410,367,000 | 204,375,000 | 204,256,000 | 206,327,000 | -423,687,000 | |
| EBITDA | $1.39B | $1.39B | $1.02B | · | $868M | $1.04B | $706M | · | $672M | $553M | $823M | · | $670M | $561M | $633M | · |
Balanço Patrimonial 27
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.82B | $2.18B | $1.75B | $4.36B | $2.23B | $1.98B | $3.22B | $3.13B | $3.31B | $2.07B | $2.87B | $2.59B | $1.39B | $1.54B | $1.69B | $3.39B | |
| Receivables | $25.45B | $24.89B | $25.98B | $25.23B | $24.56B | $23.72B | $24.55B | $23.87B | $24.05B | $22.64B | $21.58B | · | $20.80B | $19.49B | $18.63B | · | |
| Inventory | $21.03B | $20.01B | $24.08B | $20.49B | $20.14B | $18.97B | $20.51B | $19.00B | $18.30B | $17.63B | $18.65B | · | $16.85B | $16.96B | $16.78B | · | |
| Prepaid Expense | $636M | $637M | $678M | $539M | $451M | $575M | $516M | $539M | $460M | $512M | $493M | · | $493M | $488M | $1.99B | · | |
| Current Assets | $55.34B | $53.14B | $54.15B | $52.24B | $48.81B | $46.53B | $49.99B | $47.72B | $47.31B | $44.16B | $44.86B | · | $40.99B | $39.99B | $40.71B | · | |
| PP&E (Net) | $2.84B | $2.81B | $2.45B | $2.54B | $2.43B | $2.30B | $2.10B | $2.18B | $2.08B | $2.09B | $2.12B | · | $2.15B | $2.15B | $2.14B | · | |
| PP&E (Gross) | · | · | · | $5.73B | · | · | · | $5.22B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $3.19B | · | · | · | $3.03B | · | · | · | · | · | · | · | · | |
| Goodwill | $16.52B | $16.45B | $13.73B | $13.68B | $14.33B | $14.09B | $9.18B | $9.32B | $9.61B | $9.62B | $9.66B | $9.57B | $9.66B | $9.63B | $8.60B | $8.50B | |
| Intangibles | $5.93B | $6.05B | $3.68B | $3.77B | $3.93B | $3.86B | $3.68B | $4.00B | $4.01B | $4.18B | $4.38B | · | $4.77B | $4.88B | $4.43B | · | |
| Other Non-current Assets | $3.01B | $3.01B | $4.14B | $4.15B | $4.23B | $4.17B | $3.89B | $3.64B | $3.53B | $3.57B | $3.46B | · | $3.40B | $1.88B | $1.80B | · | |
| Total Assets | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Accounts Payable | $54.70B | $51.88B | $56.06B | $54.72B | $51.04B | $50.11B | $49.91B | $50.94B | $49.88B | $46.32B | $47.74B | · | $43.75B | $42.73B | $41.76B | · | |
| Accrued Liabilities | $3.35B | $3.20B | $2.73B | $2.98B | $2.72B | $2.45B | $2.39B | $2.76B | $2.53B | $2.37B | $2.44B | · | $2.17B | $2.07B | $2.01B | · | |
| Current Liabilities | $59.20B | $56.13B | $59.13B | $57.82B | $53.96B | $53.33B | $54.51B | $54.28B | $52.97B | $49.76B | $50.77B | · | $46.78B | $45.07B | $44.76B | · | |
| Capital Leases | · | · | · | $1.42B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | |
| Deferred Tax | $1.79B | $1.75B | $1.64B | $1.62B | $1.61B | $1.62B | $1.59B | $1.64B | $1.61B | $1.70B | $1.69B | · | $1.72B | $1.74B | $1.63B | · | |
| Other Non-current Liabilities | $3.97B | $3.79B | $3.70B | $3.64B | $3.54B | $3.42B | $2.06B | $1.99B | $1.93B | $1.96B | $1.91B | · | $1.86B | $1.06B | $992M | · | |
| Long-term Debt | $11.72B | $12.39B | $7.92B | $7.66B | $8.24B | $7.86B | $8.15B | $4.39B | $4.73B | $5.25B | $4.78B | · | · | · | · | · | |
| Total Debt | $11.44B | $12.18B | $7.58B | · | $8.04B | $7.09B | $5.94B | · | $4.17B | $4.18B | $4.19B | · | $4.16B | $4.67B | $4.66B | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | |
| Retained Earnings | $9.14B | $8.49B | $6.97B | $6.53B | $6.98B | $6.40B | $5.79B | $5.42B | $5.51B | $5.13B | $4.82B | · | $4.07B | $3.69B | $3.36B | · | |
| Treasury Stock | $11.45B | $10.44B | $10.43B | $10.33B | $10.33B | $10.33B | $10.28B | $9.82B | $9.30B | $8.75B | $8.69B | · | $7.97B | $7.87B | $7.86B | · | |
| AOCI | $-980M | $-961M | $-905M | $-901M | $-844M | $-1.20B | $-1.40B | $-989M | $-1.28B | $-1.26B | $-1.14B | · | $-1.23B | $-1.32B | $-1.41B | · | |
| Stockholders' Equity | $3.05B | $3.40B | $1.91B | $1.51B | $1.98B | $1.01B | $227M | $646M | $925M | $1.08B | $912M | · | $686M | $282M | $-178M | · | |
| Liabilities + Equity | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Shares Outstanding | 190,826,409 | 194,560,641 | 194,521,885 | 193,937,673 | 193,860,959 | 193,783,768 | 193,849,411 | 194,943,968 | 197,008,633 | 199,388,633 | 199,461,864 | · | 202,109,227 | 202,410,686 | 202,225,546 | · |
Fluxo de Caixa 17
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $269M | $249M | $260M | $259M | $254M | $260M | $278M | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $29M | $28M | $66M | $26M | $23M | $28M | $70M | $35M | $22M | $28M | $63M | $25M | $21M | $23M | $56M | $16M | |
| Deferred Tax | $55M | $178M | $14M | $55M | $-17M | $26M | $-5M | $4M | $-70M | $-40M | $3M | $-29M | $-28M | $-49M | $-12M | $139M | |
| Amort. of Intangibles | $119M | $117M | $126M | $127M | $126M | $138M | $166M | $167M | $165M | $166M | $166M | $171M | $170M | $141M | $72M | $73M | |
| Restructuring | $61M | $41M | $14M | $89M | $42M | $53M | $46M | $81M | $42M | $76M | $34M | $52M | $64M | $97M | $16M | $-146M | |
| Other Non-cash | · | · | $-3.21B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.65B | $1.34B | $-2.31B | $3.13B | $109M | $3.35B | $-2.72B | $1.00B | $2.48B | $-878M | $885M | $1.83B | $745M | $630M | $710M | $1.16B | |
| CapEx | $226M | $166M | $119M | $250M | $183M | $129M | $106M | $182M | $118M | $113M | $74M | $175M | $104M | $103M | $76M | $174M | |
| Investing Cash Flow | $-240M | $-4.87B | $-299M | $-322M | $-235M | $-4.08B | $-343M | $-242M | $-144M | $-166M | $-66M | $-183M | $-819M | $-89M | $-1.51B | $-175M | |
| Debt Issued | · | · | · | · | · | · | · | · | $53M | $545M | $90M | · | $89M | $13M | $55M | · | |
| Net Debt Issued | · | · | $-132M | · | · | · | $-45M | · | · | · | $6M | · | · | · | $2M | · | |
| Stock Repurchased | · | · | · | $71.0K | $0 | $50M | $385M | $505M | $550M | $51M | $386M | $274M | $100M | $0 | $807M | $235M | |
| Net Stock Activity | · | · | · | · | · | · | $-385M | · | · | · | $-386M | · | · | · | $-807M | · | |
| Dividends Paid | $117M | $117M | $127M | $108M | $107M | $111M | $111M | $101M | $103M | $107M | $106M | $98M | $99M | $102M | $100M | $96M | |
| Financing Cash Flow | $-1.77B | $3.98B | $43M | $-684M | $215M | $-492M | $3.21B | $-957M | $-1.15B | $323M | $-552M | $-407M | $-82M | $-769M | $-964M | $-673M | |
| Net Change in Cash | $629M | $428M | $-2.59B | $2.12B | $97M | $-1.22B | $97M | $-179M | $1.19B | $-751M | $283M | $1.20B | $-140M | $-224M | $-1.68B | $291M | |
| Free Cash Flow | · | · | $-2.42B | · | · | · | $-2.82B | · | · | · | $811M | · | · | · | $634M | · |
Lucratividade 8
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 4.3% | 4.6% | 3.6% | · | 3.6% | 4.1% | 3.1% | · | 3.2% | 3.7% | 3.4% | · | 3.4% | 3.6% | 3.4% | · | |
| Operating Margin | 1.3% | 1.5% | 0.88% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| Net Margin | 0.90% | 2.1% | 0.65% | · | 0.85% | 0.95% | 0.60% | · | 0.65% | 0.62% | 0.83% | · | 0.72% | 0.69% | 0.76% | · | |
| Pretax Margin | 1.2% | 2.7% | 0.82% | · | 1.1% | 1.2% | 0.76% | · | 0.85% | 0.68% | 1.1% | · | 0.91% | 0.81% | 0.94% | · | |
| EBITDA Margin | 1.6% | 1.8% | 1.2% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| ROA | 0.97% | 2.1% | 0.76% | · | 0.98% | 1.1% | 0.73% | · | 0.76% | 0.69% | 0.98% | · | 0.81% | 0.75% | 0.83% | · | |
| ROE | 30.3% | 74.4% | 52.4% | · | 47.3% | 68.5% | 85.9% | · | 60.0% | 61.7% | 164.0% | · | 105.4% | 104.7% | 1513.0% | · | |
| ROIC | 6.0% | 5.7% | 6.4% | · | 6.7% | 9.9% | 9.1% | · | 10.2% | 9.5% | 12.4% | · | 10.9% | 9.5% | 11.3% | · |
Liquidez e Solvência 4
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | |
| Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · | |
| LT Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · |
Eficiência 3
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | |
| Inventory Turnover | 3.9 | 3.8 | 3.7 | · | 4.0 | 4.0 | 4.0 | · | 4.1 | 3.8 | 3.9 | · | 4.0 | 3.8 | 3.7 | · | |
| Receivables Turnover | 3.4 | 3.2 | 3.4 | · | 3.3 | 3.3 | 3.5 | · | 3.3 | 3.2 | 3.6 | · | 3.4 | 3.4 | 3.5 | · |
Avaliação (TTM) 14
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $329.71B | $320.41B | $323.54B | · | $311.85B | $299.60B | $296.40B | · | $281.86B | $271.07B | $265.50B | · | $253.32B | $244.09B | $240.26B | · | |
| Net Income TTM | $3.65B | $3.61B | $2.45B | · | $2.38B | $2.11B | $1.99B | · | $1.99B | $1.94B | $2.00B | · | $1.80B | $1.87B | $1.88B | · | |
| Market Cap | $54.00B | $61.12B | $65.70B | · | $58.13B | $53.89B | $43.55B | · | $44.39B | $48.45B | $40.97B | · | $38.89B | $32.41B | $33.51B | · | |
| Enterprise Value | $62.63B | $71.13B | $71.53B | · | $63.94B | $59.00B | $46.27B | · | $45.25B | $50.56B | $42.28B | · | $41.66B | $35.54B | $36.47B | · | |
| P/E | 15.1 | 17.0 | 26.9 | · | 24.7 | 26.0 | 22.5 | · | 22.9 | 25.4 | 21.0 | · | 22.0 | 17.8 | 18.5 | · | |
| P/S | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | |
| P/B | 17.7 | 18.0 | 34.4 | · | 29.4 | 53.2 | 192.2 | · | 48.0 | 44.7 | 44.9 | · | 56.7 | 115.0 | -188.1 | · | |
| P / Cash Flow | · | · | -28.5 | · | · | · | -16.0 | · | · | · | 46.3 | · | · | · | 47.2 | · | |
| P / FCF | · | · | -27.1 | · | · | · | -15.4 | · | · | · | 50.5 | · | · | · | 52.8 | · | |
| EV / EBITDA | 45.1 | 51.1 | 70.1 | · | 73.7 | 56.9 | 65.5 | · | 67.3 | 91.4 | 51.4 | · | 62.2 | 63.4 | 57.6 | · | |
| EV / FCF | · | · | -29.5 | · | · | · | -16.4 | · | · | · | 52.1 | · | · | · | 57.5 | · | |
| EV / Revenue | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | |
| Earnings Yield | 6.6% | 5.9% | 3.7% | · | 4.0% | 3.8% | 4.5% | · | 4.4% | 3.9% | 4.8% | · | 4.5% | 5.6% | 5.4% | · | |
| Payout Ratio | · | · | 22.6% | · | · | · | 22.7% | · | · | · | 17.6% | · | · | · | 20.8% | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Receita | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B |
| Margem Bruta % | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% |
| Margem Operacional % | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% |
| Lucro líquido | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B |
| EPS Diluído | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 |
Balanço Patrimonial
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 |
| Índice de liquidez corrente | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Índice de Liquidez Seca | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Fluxo de Caixa
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B |
Últimas notícias Notícias recentes mencionando esta empresa
- IYK, MCK, CTVA, COR: ETF Outflow Alert
- Sexta-feira 29/5 Relatório de Compras Internas: SCHW, COR
- Cencora (COR) Emerge como Líder em Saúde com Fundamentos Robustos e Reavaliação Estratégica
- Destaques da Chamada de Lucros do Cencora no Q2
- Cencora Inc. Q2 26 Earnings Conference Call 8:30 A.m. ET
- O Que Você Precisa Saber Antes do Relatório de Ganhos da Cencora
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 1.493 declarantes · $31.4B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 102 (-56 vs trimestre anterior) | 172 (+41 vs trimestre anterior) | 434 (-101 vs trimestre anterior) | 595 (+65 vs trimestre anterior) | +8.4M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3.502.993.290 | 12.378.943 | 11,14% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.719.934.713 | 9.611.756 | 8,65% | Ações |
| STATE STREET CORP | $2.624.351.709 | 9.273.983 | 8,34% | Ações |
| Walgreens Boots Alliance, Inc. | $2.240.779.050 | 7.473.000 | 7,12% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.358.112.555 | 4.819.419 | 4,32% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $1.231.165.897 | 4.350.717 | 3,91% | Ações |
| FMR LLC | $850.228.724 | 3.004.554 | 2,70% | Ações |
| NORGES BANK | $700.042.999 | 2.473.825 | 2,23% | Ações |
| Capital Research Global Investors | $560.283.987 | 1.979.942 | 1,78% | Ações |
| Carmignac Gestion | $494.462.712 | 1.747.363 | 1,57% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $483.772.138 | 1.709.563 | 1,54% | Ações |
| Mawer Investment Management Ltd. | $421.312.792 | 1.488.843 | 1,34% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $410.282.013 | 1.449.862 | 1,30% | Ações |
| CITADEL ADVISORS LLC | $347.541.038 | 1.228.147 | 1,11% | Ações |
| AMERICAN CENTURY COMPANIES INC | $338.738.459 | 1.197.038 | 1,08% | Ações |
| NEUBERGER BERMAN GROUP LLC | $315.929.430 | 1.116.828 | 1,00% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $313.668.332 | 1.108.447 | 1,00% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $313.605.793 | 1.108.226 | 1,00% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $294.327.781 | 1.040.101 | 0,94% | Ações |
| Sumitomo Mitsui Trust Group, Inc. | $293.610.144 | 1.037.565 | 0,93% | Ações |
| MILLENNIUM MANAGEMENT LLC | $268.966.547 | 950.479 | 0,86% | Ações |
| LAZARD ASSET MANAGEMENT LLC | $261.088.180 | 922.638 | 0,83% | Ações |
| Caisse de depot et placement du Quebec | $258.709.937 | 914.234 | 0,82% | Ações |
| Boston Partners | $231.295.970 | 817.358 | 0,74% | Ações |
| National Pension Service | $208.758.025 | 737.713 | 0,66% | Ações |
| GOLDMAN SACHS GROUP INC | $208.660.680 | 737.369 | 0,66% | Ações |
| ALLIANCEBERNSTEIN L.P. | $205.281.694 | 653.472 | 0,65% | Ações |
| NORDEA INVESTMENT MANAGEMENT AB | $180.668.066 | 644.564 | 0,57% | Ações |
| Burgundy Asset Management Ltd. | $174.893.972 | 599.753 | 0,56% | Ações |
| Balyasny Asset Management L.P. | $172.225.024 | 608.612 | 0,55% | Ações |
| Point72 Asset Management, L.P. | $171.131.023 | 604.746 | 0,54% | Ações |
| Assenagon Asset Management S.A. | $166.084.924 | 586.914 | 0,53% | Ações |
| Squarepoint Ops LLC | $154.024.599 | 544.295 | 0,49% | Ações |
| Swiss National Bank | $147.506.155 | 521.260 | 0,47% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $141.101.751 | 498.628 | 0,45% | Ações |
| Swedbank AB | $134.859.213 | 476.568 | 0,43% | Ações |
| TimesSquare Capital Management, LLC | $132.589.070 | 422.070 | 0,42% | Ações |
| Legal & General Group Plc | $129.674.734 | 458.247 | 0,41% | Ações |
| RHUMBLINE ADVISERS | $123.138.883 | 435.151 | 0,39% | Ações |
| Vanguard Global Advisers, LLC | $120.449.305 | 425.646 | 0,38% | Ações |
| BlackRock, Inc. | $119.463.969 | 422.164 | 0,38% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $117.740.633 | 416.074 | 0,37% | Ações |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $113.208.499 | 400.058 | 0,36% | Ações |
| California Public Employees Retirement System | $110.655.367 | 391.036 | 0,35% | Ações |
| BANK OF AMERICA CORP /DE/ | $105.342.134 | 372.260 | 0,33% | Ações |
| SEB Asset Management AB | $104.030.095 | 367.624 | 0,33% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $101.511.435 | 358.723 | 0,32% | Ações |
| VANGUARD GROUP INC | $100.694.421 | 298.133 | 0,32% | Ações |
| Walleye Capital LLC | $98.419.595 | 347.797 | 0,31% | Ações |
| MIZUHO MARKETS AMERICAS LLC | $96.213.200 | 340.000 | 0,31% | Ações |
| JOHNSON INVESTMENT COUNSEL INC | $93.893.214 | 331.802 | 0,30% | Ações |
| STOREBRAND ASSET MANAGEMENT AS | $93.049.484 | 328.820 | 0,30% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $88.657.847 | 282.224 | 0,28% | Ações |
| Cornerstone Investment Partners, LLC | $86.260.510 | 304.829 | 0,27% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85.771.238 | 303.100 | 0,27% | Opção de compra |
| JONES FINANCIAL COMPANIES LLLP | $85.147.559 | 297.583 | 0,27% | Ações |
| CIBC Private Wealth Group LLC | $83.133.772 | 266.003 | 0,26% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $81.593.038 | 288.335 | 0,26% | Ações |
| FIL Ltd | $79.588.408 | 281.251 | 0,25% | Ações |
| LPL Financial LLC | $76.804.992 | 271.415 | 0,24% | Ações |
| TD Asset Management Inc | $76.770.210 | 271.292 | 0,24% | Ações |
| BANK OF MONTREAL /CAN/ | $70.057.359 | 247.570 | 0,22% | Ações |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $69.812.864 | 246.706 | 0,22% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $68.792.155 | 243.099 | 0,22% | Ações |
| CITADEL ADVISORS LLC | $68.622.650 | 242.500 | 0,22% | Opção de compra |
| FIRST MANHATTAN CO. LLC. | $68.126.586 | 240.747 | 0,22% | Ações |
| AMERIPRISE FINANCIAL INC | $67.675.233 | 239.152 | 0,22% | Ações |
| TREMBLANT CAPITAL GROUP | $67.203.788 | 237.486 | 0,21% | Ações |
| RAYMOND JAMES FINANCIAL INC | $64.886.066 | 229.296 | 0,21% | Ações |
| EARNEST PARTNERS LLC | $63.127.461 | 223.081 | 0,20% | Ações |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | $60.624.220 | 214.235 | 0,19% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $60.395.855 | 213.428 | 0,19% | Ações |
| JENNISON ASSOCIATES LLC | $60.017.829 | 212.092 | 0,19% | Ações |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $59.924.694 | 211.763 | 0,19% | Ações |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $57.032.921 | 201.544 | 0,18% | Ações |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $52.864.060 | 186.812 | 0,17% | Ações |
| BARCLAYS PLC | $51.304.557 | 181.301 | 0,16% | Ações |
| Mitsubishi UFJ Trust & Banking Corp | $51.082.984 | 180.518 | 0,16% | Ações |
| PFA Pension, Forsikringsaktieselskab | $50.217.651 | 177.460 | 0,16% | Ações |
| MARSHALL WACE, LLP | $50.044.447 | 176.848 | 0,16% | Ações |
| Susquehanna Portfolio Strategies, LLC | $49.878.621 | 176.262 | 0,16% | Ações |
| Sio Capital Management, LLC | $49.121.932 | 173.588 | 0,16% | Ações |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $48.634.175 | 162.136 | 0,15% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $48.419.177 | 171.284 | 0,15% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $47.513.047 | 151.248 | 0,15% | Ações |
| AVIVA PLC | $47.242.096 | 166.945 | 0,15% | Ações |
| Jefferies Financial Group Inc. | $46.356.935 | 163.817 | 0,15% | Ações |
| Brandywine Global Investment Management, LLC | $45.181.831 | 133.773 | 0,14% | Ações |
| Asset Management One Co., Ltd. | $44.176.566 | 140.627 | 0,14% | Ações |
| Trajan Wealth LLC | $43.325.888 | 153.106 | 0,14% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $43.248.965 | 152.834 | 0,14% | Ações |
| Ensign Peak Advisors, Inc | $42.869.206 | 151.492 | 0,14% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $42.457.470 | 150.037 | 0,14% | Ações |
| UBS Group AG | $41.937.353 | 148.199 | 0,13% | Ações |
| Freestone Grove Partners LP | $41.195.379 | 145.577 | 0,13% | Ações |
| Qube Research & Technologies Ltd | $40.558.109 | 143.325 | 0,13% | Ações |
| VAN ECK ASSOCIATES CORP | $40.356.344 | 142.612 | 0,13% | Ações |
| MACKENZIE FINANCIAL CORP | $40.057.234 | 141.555 | 0,13% | Ações |
| DONALDSON CAPITAL MANAGEMENT, LLC | $38.839.791 | 137.253 | 0,12% | Ações |
| ROYAL BANK OF CANADA | $37.959.000 | 134.139 | 0,12% | Ações |
Executivos da empresa 49 insiders · 23 diretores · 27 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Robert P. Mauch | President & CEO | 18 de Junho de 2025 M | 44.094 | 0 | 0 | $0 |
| David R Yost | CEO | 17 de Maio de 2011 M | 1.530.341 | 0 | 0 | $0 |
| Eva C Boratto | Chief Financial Officer | 29 de Junho de 2026 A | — | 0 | 0 | $0 |
| Tim G. Guttman | Chief Financial Officer | 9 de Novembro de 2018 M | 53.505 | 0 | 0 | $0 |
| Michael D Dicandilo | Executive VP & CFO | 2 de Maio de 2011 M | 89.698 | 0 | 0 | $0 |
| Kurt J Hilzinger | President & COO | 15 de Fevereiro de 2007 A | 176.400 | 0 | 0 | $0 |
| Elizabeth S Campbell | Executive Vice President | 30 de Junho de 2026 A | 30.756 | 0 | 0 | $0 |
| Silvana Battaglia | Executive Vice President | 30 de Junho de 2026 A | 23.624 | 0 | 0 | $0 |
| Steven H Collis | Executive Chairman | 16 de Setembro de 2025 M | 305.913 | 0 | 2 | $-13.314.729 |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 29 de Maio de 2025 S | 17.154 | 0 | 0 | $0 |
| Leslie E Donato | EVP & Chief Strategy Officer | 28 de Junho de 2024 A | 9.525 | 0 | 0 | $0 |
| Gina Clark | Executive Vice President | 31 de Maio de 2024 S | 13.284 | 0 | 0 | $0 |
| John G. Chou | Executive Vice President | 20 de Dezembro de 2021 G | 81.367 | 0 | 0 | $0 |
| Kathy H. Gaddes | Executive Vice President | 21 de Fevereiro de 2020 M | 6.906 | 0 | 0 | $0 |
| Dale Danilewitz | Executive Vice President | 23 de Maio de 2019 S | 1.085 | 0 | 0 | $0 |
| Howell Peyton R | Executive Vice President | 4 de Abril de 2018 M | 47.989 | 0 | 0 | $0 |
| Sun Park | Executive Vice President | 17 de Novembro de 2017 F | 3.010 | 0 | 0 | $0 |
| James Frary | Executive Vice President | 9 de Novembro de 2016 A | 34.195 | 0 | 0 | $0 |
| Lawrence Marsh | Executive Vice President | 29 de Abril de 2016 F | 8.897 | 0 | 0 | $0 |
| David W Neu | Executive Vice President | 13 de Novembro de 2015 F | 5.224 | 0 | 0 | $0 |
| June Barry | Executive Vice President | 13 de Novembro de 2015 M | 4.068 | 0 | 0 | $0 |
| Jeanne B. Fisher | Senior Vice President | 1 de Fevereiro de 2010 M | 27.190 | 0 | 0 | $0 |
| Terrance P Haas | Senior Vice President | 27 de Fevereiro de 2008 A | 25.728 | 0 | 0 | $0 |
| Lauren M Tyler | Conselheiro | 31 de Julho de 2026 A | 4.456 | 1 | 0 | $148.626 |
| Dennis M Nally | Conselheiro | 31 de Julho de 2026 A | 13.188 | 0 | 0 | $0 |
| Ellen Cooper | Conselheiro | 31 de Julho de 2026 A | 893 | 0 | 0 | $0 |
| Dermot Mark Durcan | Conselheiro | 18 de Junho de 2026 P | 31.767 | 2 | 0 | $2.161.800 |
| Lori Ryerkerk | Conselheiro | 1 de Julho de 2025 A | 516 | 0 | 0 | $0 |
| Werner Baumann | Conselheiro | 1 de Maio de 2025 A | 2.896 | 0 | 0 | $0 |
| Redonda Miller | Conselheiro | 6 de Março de 2025 A | 3.194 | 0 | 0 | $0 |
| Frank Clyburn | Conselheiro | 6 de Março de 2025 A | 1.157 | 0 | 0 | $0 |
| Lorence H. Kim | Conselheiro | 6 de Março de 2025 A | 3.524 | 0 | 0 | $0 |
| Richard W Gochnauer | Conselheiro | 11 de Março de 2024 M | 28.762 | 0 | 0 | $0 |
| Kathleen W Hyle | Conselheiro | 11 de Março de 2024 M | 24.406 | 0 | 0 | $0 |
| Henry Wadsworth Mcgee III | Conselheiro | 9 de Março de 2023 A | 20.479 | 0 | 0 | $0 |
| Jane E Henney MD | Conselheiro | 5 de Março de 2023 M | 24.685 | 0 | 0 | $0 |
| Michael J Long | Conselheiro | 5 de Março de 2023 M | 17.724 | 0 | 0 | $0 |
| Douglas R Conant | Conselheiro | 4 de Março de 2019 M | 8.062 | 0 | 0 | $0 |
| Richard C Gozon | Conselheiro | 29 de Fevereiro de 2016 M | 51.484 | 0 | 0 | $0 |
| Edward E Hagenlocker | Conselheiro | 2 de Março de 2015 M | 3.351 | 0 | 0 | $0 |
| Charles H Cotros | Conselheiro | 7 de Dezembro de 2012 M | 26.773 | 0 | 0 | $0 |
| Lawrence J Wilson | Conselheiro | 1 de Maio de 2009 A | 35.942 | 0 | 0 | $0 |
| Rodney H Brady | Conselheiro | 19 de Fevereiro de 2007 A | 52.746 | 0 | 0 | $0 |
| James R Mellor | Conselheiro | 3 de Janeiro de 2006 M | 32.246 | 0 | 0 | $0 |
| Robert E Martini | Conselheiro | 23 de Janeiro de 2004 G | 1.602.739 | 0 | 0 | $0 |
| Francis G Rodgers | Conselheiro | 3 de Novembro de 2003 A | 7.918 | 0 | 0 | $0 |
| AMERISOURCEBERGEN CORP | Detentor de 10% | 31 de Julho de 2007 J | 0 | 0 | 0 | $0 |
| James F Cleary | — | 11 de Março de 2026 M | 160.357 | 0 | 0 | $0 |
| Lon R Greenberg | — | 5 de Março de 2026 A | 18.408 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 3 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Walgreens Boots Alliance Holdings LLC, WBA Investments, Inc., Walgreens Boots Alliance, Inc. ×21 declarações | 9 de Junho de 2025 | 4,96% | Emenda | — | SEC |
| AB Acquisitions Holdings Limited, Alliance Santé Participations S.A., NEWCIP S.A., Stefano Pessina, KKR Sprint (2006) Limited, KKR 2006 Fund (Overseas), Limited Partnership, KKR Associates 2006 (Overseas), Limited Partnership, KKR 2006 Limited, KKR Sprint (European II) Limited, KKR European Fund II, Limited Partnership, KKR Associates Europe II, Limited Partnership, KKR Europe II Limited, KKR Sprint (KPE) Limited, KKR PEI Investments, L.P., KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts | 23 de Janeiro de 2015 | — | Declaração inicial | — | SEC |
| WAB Holdings LLC, Walgreens Pharmacy Strategies, LLC, Bond Drug Company of Illinois, LLC, Walgreen Eastern Co., Inc., Walgreen Arizona Drug Co., Walgreen Hastings Co., Walgreen International Investments LLC, WBA Investments, LLC, Walgreen Co., Alliance Boots Luxembourg S.à r.l., Alliance Boots Holdings Limited, AB Acquisitions UK Holdco 7 Limited, AB Acquisitions Limited, Alliance Boots International Limited, Alliance Boots Limited, AB Acquisitions UK Topco Limited, AB Acquisitions Luxco 1 S.à r.l., Alliance Boots GmbH, Walgreen Swiss International GmbH, Ontario Holdings WBA Limited, Walgreen International S.à r.l., Superior Bermuda GP, Superior Luxco 3 S.à r.l., Walgreens Boots Alliance Scottish LP, WBA 1 Scottish LLP, Superior Luxco 2 S.à r.l., Superior Luxco 1 S.à r.l., Walgreen Investments Luxembourg SCS, Walgreen Investments Co, Walgreens Boots Alliance, Inc. ×2 declarações | 16 de Janeiro de 2015 | — | Declaração inicial | Campanha no conselho | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 212 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| JMID · Janus Detroit Street Trust | 3,11% | 1.841 NS | 30 de Abril de 2026 | N-PORT |
| IYK · iShares Trust | 2,76% | 121.004 SH | 8 de Agosto de 2026 | Diário |
| FXG · First Trust Exchange-Traded AlphaDE… | 2,40% | 19.060 NS | 30 de Abril de 2026 | N-PORT |
| PAWZ · ProShares Trust | 2,36% | 2.847 NS | 31 de Maio de 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 2,34% | 1.750 NS | 31 de Maio de 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,26% | 12.908 SH | 8 de Agosto de 2026 | Diário |
| MEDI · Harbor ETF Trust | 2,16% | 1.935 NS | 30 de Abril de 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,91% | 186 NS | 30 de Abril de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,83% | 568.607 SH | 8 de Agosto de 2026 | Diário |
| SWP · Manager Directed Portfolios | 1,75% | 10.059 NS | 31 de Maio de 2026 | N-PORT |
| IWP · iShares Trust | 1,73% | 1.079.322 SH | 8 de Agosto de 2026 | Diário |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 42.128 SH | 8 de Agosto de 2026 | Diário |
| QIDX · Spinnaker ETF Series | 1,66% | 2.065 NS | 30 de Abril de 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1,56% | 228 NS | 30 de Abril de 2026 | N-PORT |
| USMV · iShares Trust | 1,29% | 958.985 SH | 8 de Agosto de 2026 | Diário |
| ESMV · iShares Trust | 1,27% | 308 SH | 8 de Agosto de 2026 | Diário |
| UPSD · ETF Series Solutions | 1,21% | 3.966 NS | 30 de Abril de 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,17% | 7.354 NS | 30 de Abril de 2026 | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1,17% | 1.161 NS | 30 de Abril de 2026 | N-PORT |
| ACWV · iShares, Inc. | 1,17% | 120.628 SH | 8 de Agosto de 2026 | Diário |
| FMAG · FIDELITY COVINGTON TRUST | 1,10% | 9.066 NS | 30 de Abril de 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1,10% | 73.945 NS | 30 de Abril de 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1,03% | 608.442 NS | 30 de Abril de 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,02% | 1.555 NS | 30 de Abril de 2026 | N-PORT |
| GROZ · Zacks Trust | 0,93% | 3.136 NS | 31 de Maio de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,92% | 84.961 NS | 30 de Abril de 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,90% | 1.187.313 SH | 8 de Agosto de 2026 | Diário |
| CURE · Direxion Shares ETF Trust | 0,86% | 3.879 NS | 30 de Abril de 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,85% | 45.117 SH | 8 de Agosto de 2026 | Diário |
| IMCG · iShares Trust | 0,84% | 105.034 SH | 8 de Agosto de 2026 | Diário |
| IXJ · iShares Trust | 0,80% | 102.068 SH | 8 de Agosto de 2026 | Diário |
| ALTL · Pacer Funds Trust | 0,79% | 2.471 NS | 30 de Abril de 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,79% | 6.030 NS | 30 de Abril de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,77% | 555.571 SH | 8 de Agosto de 2026 | Diário |
| PALC · Pacer Funds Trust | 0,76% | 5.696 NS | 30 de Abril de 2026 | N-PORT |
| RXL · ProShares Trust | 0,76% | 2.029 NS | 31 de Maio de 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,75% | 285 NS | 31 de Maio de 2026 | N-PORT |
| ROE · EA Series Trust | 0,73% | 7.012 NS | 29 de Maio de 2026 | N-PORT |
| TAX · EA Series Trust | 0,72% | 680 NS | 29 de Maio de 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,68% | 342 NS | 30 de Abril de 2026 | N-PORT |
| DUHP · Dimensional ETF Trust | 0,68% | 249.048 NS | 30 de Abril de 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,66% | 3.314 NS | 31 de Maio de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,63% | 18.623 SH | 8 de Agosto de 2026 | Diário |
| VO · VANGUARD INDEX FUNDS | 0,50% | 4.005.623 SH | 8 de Agosto de 2026 | Diário |
| QARP · DBX ETF Trust | 0,49% | 1.374 NS | 29 de Maio de 2026 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0,47% | 2.120 NS | 31 de Maio de 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,44% | 77.004 NS | 30 de Abril de 2026 | N-PORT |
| IWR · iShares Trust | 0,43% | 760.297 SH | 8 de Agosto de 2026 | Diário |
| IMCB · iShares Trust | 0,43% | 22.227 SH | 8 de Agosto de 2026 | Diário |
| JSTC · Tidal Trust I | 0,40% | 4.993 NS | 31 de Maio de 2026 | N-PORT |